Evidence map›Paper›PMID 40166332›Full record

ArticlebioRxiv : the preprint server for biology2025

Athar Khalil, Trang Dinh, Meaghan Parks, Rebecca C Obeng, Berkley Gryder, Adam Kresak, Yuxiang Wang, Jeff Maltas, Madeline Bedrock, Xiangzhen Wei and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    2026
5 · Who and what money

Authors and funding

16 authors.

Athar Khalil
Trang Dinh
Meaghan Parks
Rebecca C Obeng
Berkley Gryder
Adam Kresak
Yuxiang Wang
Jeff Maltas
Madeline Bedrock
Xiangzhen Wei
Zachary Faber
Mira Rahm
Jacob Scott
Thomas LaFramboise
Zhenghe Wang
Christopher McFarland

Funding

Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutationsR01CA196643 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Zhenghe Wang · 2016 to 2026
$3.1M
Role of Erbb3 kinase activity in colorectal tumorigenesis.R01CA256791 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2021 to 2025
$2.5M
Role of PTPRT in colon cancer progression and metastasisR01CA260629 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2022 to 2025
$2.2M
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesisR01CA264320 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, ZHENGHE · 2021 to 2025
$2.0M
Mechanisms of lincDUSP Oncogenic Effects in Colon CancerR01CA217992 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LAFRAMBOISE, THOMAS LOUIS · 2018 to 2023
$1.8M
NCI NIH HHS R01 CA196643NCI NIH HHS R01 CA217992NCI NIH HHS R01 CA256791NCI NIH HHS R01 CA260629NCI NIH HHS R01 CA264320
6 · The paper itself

Abstract

The TBX2 subfamily of T-box transcription factors (including

Identifiers

PMID40166332
PMCPMC11956923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.